Pivotal bioVenture Partners closed over $300 mln for debut fund

Pivotal bioVenture Partners has raised over $300 million for its maiden fund. Pivotal bioVenture Partners Fund I will focus on backing early-stage biotech companies.

16 March 2017•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail